TargED Biopharmaceuticals B.V

BiotechnologySeries AUtrecht, Netherlandstargedbiopharmaceuticals.com

Latest round

Series A

Last raised

Dec 2025

Total raised

$71M

Investors

9

About TargED Biopharmaceuticals B.V

Based in Utrecht, Netherlands, and founded in 2018 by CEO Kristof Vercruysse and co-founders Marc van Moorsel, Steven de Maat, and Coen Maas.V develops drugs by using small antibodies to deliver enzymes to sites of thrombosis, enabling targeted thrombolysis. Its lead product is a Microlyse clot-busting compound that binds to a protein present in all forms of thrombosis. Its mechanism of action allows for potential applications in a variety of indications involving thrombosis, including the life-threatening disease Thrombotic Thrombocytopenic Purpura.

Who invested in TargED Biopharmaceuticals B.V

9 investors across 3 rounds

See all investors in TargED Biopharmaceuticals B.V

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 16, 2025

    Amount

    $25M

    Investors

    Locked

  2. Series A

    Feb 22, 2022

    Amount

    $44M

    Investors

    Locked

  3. Seed

    Nov 24, 2020

    Amount

    $1.6M

    Investors

    Locked

Questions about TargED Biopharmaceuticals B.V

Who invested in TargED Biopharmaceuticals B.V?

TargED Biopharmaceuticals B.V has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has TargED Biopharmaceuticals B.V raised?

TargED Biopharmaceuticals B.V has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did TargED Biopharmaceuticals B.V last raise money?

TargED Biopharmaceuticals B.V's most recent round on record is a Series A, in Dec 2025.

What does TargED Biopharmaceuticals B.V do?

Based in Utrecht, Netherlands, and founded in 2018 by CEO Kristof Vercruysse and co-founders Marc van Moorsel, Steven de Maat, and Coen Maas.

Where is TargED Biopharmaceuticals B.V headquartered?

TargED Biopharmaceuticals B.V is headquartered in Utrecht, Netherlands.

Which VCs invest in companies like TargED Biopharmaceuticals B.V?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at TargED Biopharmaceuticals B.V's stage. Their profiles are linked below.

Raising like TargED Biopharmaceuticals B.V? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.